Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer' Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07122856
What this trial is testing

Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients

Who this might be right for
Alzheimer DiseaseMini-Mental State ExaminationCognitive Dysfunction+2 more
Centre Hospitalier de Gonesse 100
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Not applicableStudy completedNCT04628702
What this trial is testing

Playful Multimodal Intervention, Monitoring and Decision Support for Activation of People With Alzheimer's Dementia

Who this might be right for
Alzheimer Disease
Medical University of Graz 24
Not applicableUnknownNCT01570322
What this trial is testing

Determinants of Quality of Life Related to Health in Alzheimer Disease

Who this might be right for
Alzheimer Disease
CHU de Reims 400
Testing effectiveness (Phase 2)Ended earlyNCT00069849
What this trial is testing

The Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Abbott 64
Post-approval studies (Phase 4)Study completedNCT01054976
What this trial is testing

The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Korea, Ltd., Korea 99
Not applicableStudy completedNCT00597376
What this trial is testing

Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints

Who this might be right for
Subjective Memory Loss in Older Persons
Rush University Medical Center 104
Post-approval studies (Phase 4)Ended earlyNCT01832350
What this trial is testing

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseasePseudobulbar Affect (PBA)
St. Joseph's Hospital and Medical Center, Phoenix 34
Large-scale testing (Phase 3)Active Not RecruitingNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 1,060
Early research (Phase 1)Study completedNCT00906191
What this trial is testing

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 6
Not applicableStudy completedNCT02521818
What this trial is testing

Dietary Treatments for Cognitive Impairment in Older Adults

Who this might be right for
Mild Cognitive ImpairmentProbable Alzheimer's Disease
Johns Hopkins University 38
Not applicableStudy completedNCT04730440
What this trial is testing

Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease

Who this might be right for
Alzheimer DementiaFamily Caregivers
Centre Hospitalier Princesse Grace 8
Testing effectiveness (Phase 2)Study completedNCT03069014
What this trial is testing

Study of LM11A-31-BHS in Mild-moderate AD Patients

Who this might be right for
Mild to Moderate Alzheimer's Disease
PharmatrophiX Inc. 242
Testing effectiveness (Phase 2)Active Not RecruitingNCT06402838
What this trial is testing

Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 256
Post-approval studies (Phase 4)Study completedNCT00980785
What this trial is testing

Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's

Who this might be right for
Alzheimer's DiseaseHypertension
University of Wisconsin, Madison 14
Not applicableStudy completedNCT03538574
What this trial is testing

Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers

Who this might be right for
Insomnia Chronic
University of California, Los Angeles 139
Large-scale testing (Phase 3)Study completedNCT00428389
What this trial is testing

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 262
Not applicableActive Not RecruitingNCT06291909
What this trial is testing

Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia

Who this might be right for
DementiaAlzheimer Disease
University of South Australia 88
Early research (Phase 1)Looking for participantsNCT06372821
What this trial is testing

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Who this might be right for
Alzheimer DiseaseAutosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)+1 more
University College, London 10
Not applicableStudy completedNCT03847714
What this trial is testing

Probiotics in Dementia

Who this might be right for
Dementia; Alzheimer, Mixed Type (Etiology)
Medical University of Graz 17
Next Page